Aurobindo Pharma Subsidiary Lannett Completes US FDA Inspection

Aurobindo Pharma Ltd has announced the completion of a routine US FDA inspection at its wholly owned step-down subsidiary, Lannett Company LLC, located in Seymour, IN, USA. The inspection took place from August 17th to 21st, 2026. The facility concluded the inspection with four observations, which Aurobindo Pharma has stated are procedural in nature. The company will submit its response to the US FDA within the stipulated timeline and remains committed to maintaining high quality and compliance standards across its manufacturing operations. Further developments will be communicated as required.